Eating a Mediterranean-style diet was linked to a lower chance of developing MS, and changes to how genes are switched on and off (DNA methylation) explained part of that link.
Researchers compared the diets and blood markers of 201 people with MS and 342 people without MS to look for connections between food and MS risk. People who ate more like the Mediterranean diet, including a version that allowed some unprocessed red meat, had a lower chance of getting MS. The team measured DNA methylation, which is a chemical tag that can turn genes up or down without changing the genes themselves — like putting a sticky note on a recipe to say 'use less salt.' They found a group of these methylation changes (called the A5 module) that explained about 22–30% of the diet’s link to lower MS risk, meaning part of the diet effect may work through these gene switches. The results were similar regardless of common immune-related genes (HLA types), so the diet connection was not limited to one genetic group.
People with MS or those worried about MS should care because diet might be one tool to help lower the chance of getting MS or influence how the immune system behaves, which is important in MS. Caregivers can use this as a practical idea — encouraging meals with vegetables, fruits, fish, whole grains, nuts, and olive oil may help, similar to swapping fast food for home-cooked balanced meals. Clinicians and dietitians may find this useful when advising patients about lifestyle choices that could affect immune health. Think of DNA methylation like dimming lights on immune genes; the Mediterranean diet may dim some lights that would otherwise make the immune system too active. While this is not proof that diet prevents MS, it gives a clear, everyday action people can try alongside medical care.
This study shows associations but cannot prove the diet directly causes lower MS risk, because it compared people at one point in time rather than following them over years. The DNA methylation findings explain only part of the diet link, so other factors like exercise, infections, or unmeasured foods might also matter. The study used recalled diet surveys and blood tests, which can have errors, so results should be seen as promising but not definitive guidance to replace medical advice.
AI-generated summary — for informational purposes only, not medical advice
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More12/31/2026
Researchers found consistent gut bacteria differences in MS tied to disease type, treatment response
Read More9/1/2026
A small study found Ma/Ma2 antibodies can cause nerve-only symptoms often linked to cancer; testing
Read More9/1/2026
Long-term study shows ravulizumab greatly reduced relapses in AQP4+ NMOSD over 3+ years with expecte
Read More9/1/2026
Even without common antibodies, NMOSD can be severe and relapsing; early maintenance immune treatmen
Read More7/22/2026
In mice, 4‑aminopyridine (an MS drug) reduced nerve fiber and myelin damage after head injury and cu
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Multiple sclerosis (Houndmills, Basingstoke, England) often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.